The SeriousTraders Newsletter

The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™

Newsletter Archives

SeriousTradersSpotlight Company

BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF)

Investment Considerations Flagship drug candidate BNT23001 targets the $28B MS market with a faster-acting, easier-to-administer sublingual format. Additional candidates address MG, LN, RA, longevity, and diabetes/obesity using the same thin-film technology. Gen-Plus R&D integration accelerates development, manufacturing, and European commercialization. Patent portfolio spans major global markets with flagship claims validated by the European Patent Office. … Continue reading “BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF)”

View Profile

BioNxt Solutions Inc.

Latest Press Releases

Filter Releases
Filters
Sector



Symbol Release Time
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}}
IBN (InvestorBrandNetwork)

SeriousTraders is part of the IBN (InvestorBrandNetwork). Other brands within the investor brand network include:

CannabisNewsWire (CNW)
CryptoCurrencyWire (CCW)
MissionIR (MIR)
NetworkNewsWire (NNW)
QualityStocks (QS)
QualityStocksTwits
StocksToBuyNow (STBN)
SmallCapRelations (SCR)
Tip.us
TraderPower (TP)
Interested in a live, online demonstration?

Schedule a LIVE Demo